XML 21 R71.htm IDEA: XBRL DOCUMENT v2.4.0.6
Reportable Segments (Schedule Of Reportable Segments Information By Segment) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Segment Reporting Information [Line Items]        
Net sales $ 1,908 $ 2,005 $ 3,828 $ 3,928
Depreciation     473 458
Research, development and engineering expenses 188 172 375 328
Equity in earnings (loss) of affiliated companies 259 428 477 826
Income tax (provision) benefit 93 123 204 237
Display Technologies [Member]
       
Segment Reporting Information [Line Items]        
Net sales 641 760 1,346 1,550
Depreciation 125 [1] 123 [1] 254 [1] 247 [1]
Research, development and engineering expenses 26 [2] 27 [2] 53 [2] 52 [2]
Equity in earnings (loss) of affiliated companies 184 319 366 613
Income tax (provision) benefit (78) (118) (174) (257)
Net income (loss) 371 [3] 626 [3] 792 [3] 1,264 [3]
Telecommunications [Member]
       
Segment Reporting Information [Line Items]        
Net sales 559 548 1,067 1,022
Depreciation 34 [1] 32 [1] 64 [1] 60 [1]
Amortization of purchased intangibles 2 2 5 3
Research, development and engineering expenses 35 [2] 32 [2] 70 [2] 61 [2]
Equity in earnings (loss) of affiliated companies 2 1 (2) 4
Income tax (provision) benefit (17) (22) (29) (41)
Net income (loss) 36 [3] 46 [3] 57 [3] 87 [3]
Environmental Technologies [Member]
       
Segment Reporting Information [Line Items]        
Net sales 249 258 512 517
Depreciation 29 [1] 27 [1] 57 [1] 52 [1]
Research, development and engineering expenses 26 [2] 23 [2] 52 [2] 46 [2]
Equity in earnings (loss) of affiliated companies   1 1 1
Income tax (provision) benefit (17) (15) (37) (29)
Net income (loss) 34 [3] 32 [3] 74 [3] 61 [3]
Specialty Materials [Member]
       
Segment Reporting Information [Line Items]        
Net sales 296 283 584 537
Depreciation 36 [1] 42 [1] 70 [1] 79 [1]
Research, development and engineering expenses 37 [2] 36 [2] 74 [2] 65 [2]
Equity in earnings (loss) of affiliated companies   5   8
Income tax (provision) benefit (17) (9) (28) (12)
Net income (loss) 34 [3] 23 [3] 55 [3] 31 [3]
Life Sciences [Member]
       
Segment Reporting Information [Line Items]        
Net sales 162 155 317 299
Depreciation 10 [1] 9 [1] 20 [1] 17 [1]
Amortization of purchased intangibles 2 2 4 4
Research, development and engineering expenses 5 [2] 5 [2] 11 [2] 9 [2]
Income tax (provision) benefit (5) (7) (11) (14)
Net income (loss) 11 [3] 15 [3] 23 [3] 30 [3]
All Other [Member]
       
Segment Reporting Information [Line Items]        
Net sales 1 1 2 3
Depreciation 3 [1] 3 [1] 6 [1] 5 [1]
Research, development and engineering expenses 29 [2] 24 [2] 56 [2] 46 [2]
Equity in earnings (loss) of affiliated companies 9 2 13 9
Income tax (provision) benefit 12 10 22 19
Net income (loss) (16) [3] (20) [3] (36) [3] (35) [3]
Total [Member]
       
Segment Reporting Information [Line Items]        
Net sales 1,908 2,005 3,828 3,928
Depreciation 237 [1] 236 [1] 471 [1] 460 [1]
Amortization of purchased intangibles 4 4 9 7
Research, development and engineering expenses 158 [2] 147 [2] 316 [2] 279 [2]
Equity in earnings (loss) of affiliated companies 195 328 378 635
Income tax (provision) benefit (122) (161) (257) (334)
Net income (loss) $ 470 [3] $ 722 [3] $ 965 [3] $ 1,438 [3]
[1] Depreciation expense for Corning's reportable segments includes an allocation of depreciation of corporate property not specifically identifiable to a segment.
[2] Research, development, and engineering expenses include direct project spending that is identifiable to a segment.
[3] Many of Corning's administrative and staff functions are performed on a centralized basis. Where practicable, Corning charges these expenses to segments based upon the extent to which each business uses a centralized function. Other staff functions, such as corporate finance, human resources and legal, are allocated to segments, primarily as a percentage of sales.